Medications for Glioma
4 results
Gleolan (aminolevulinic acid hydrochloride)
(AMINOLEVULINIC ACID HYDROCHLORIDE)NX DEVELOPMENT CORP
Usage: Gleolan is indicated for patients with glioma (suspected WHO Grades III or IV) to assist in the visualization of malignant tissue during surgery.
Gliadel (carmustine)
(carmustine)Arbor Pharmaceuticals
Usage: GLIADEL Wafer is indicated for treating newly-diagnosed high-grade glioma as an adjunct to surgery and radiation, and for recurrent glioblastoma as an adjunct to surgery.
Ojemda (tovorafenib)
(tovorafenib)Day One Biopharmaceuticals, Inc.
Usage: OJEMDA is indicated for treating patients aged 6 months and older with relapsed or refractory pediatric low-grade glioma (LGG) associated with a BRAF fusion, rearrangement, or BRAF V600 mutation. Approval is under accelerated conditions, pending further verification of clinical benefits.
Tafinlar (dabrafenib)
(dabrafenib)Novartis Pharmaceuticals Corporation
Usage: TAFINLAR is indicated for treating unresectable or metastatic melanoma with BRAF V600E/K mutations, as well as for adjuvant treatment post-resection. It is also used for metastatic non-small cell lung cancer, anaplastic thyroid cancer, unresectable solid tumors, and low-grade glioma in pediatric patients, all with the BRAF V600E mutation.